Federal Register / Vol. 60, No. 42 / Friday, March 3, 1995 / Notices 11975

background information relating to the

settlement, may be obtained in person

or by mail from EPA’s Region II Office

of Regional Counsel, New Jersey

Superfund Branch, 17th floor, 290

Broadway, New York, New York 10007–

1866.

Proposed Settlement under Section

122(h) of CERCLA—Rockaway Borough

Well Field Superfund Site.

Dated: February 7, 1995.

William J. Muszynski,

Deputy Regional Administrator.

[FR Doc. 95–5278 Filed 3–2–95; 8:45 am]

BILLING CODE 6560–50–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee for Injury

Prevention and Control (ACIPC);

Family and Intimate Violence

Prevention Subcommittee; Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC),

announces the following subcommittee

meeting.

Name: ACIPC Family and Intimate

Violence Prevention Subcommittee.

Time and Date: 1 p.m.–5 p.m., March 20,

1995.

Place: Holiday Inn at Lenox/Buckhead,

3377 Peachtree Road, NE, Atlanta, Georgia

30326.

Status: Open to the public, limited only by

the space available.

Purpose: The subcommittee provides

advice and makes recommendations to the

ACIPC regarding feasible goals for prevention

and control of family and intimate violence.

The subcommittee makes recommendations

regarding policies, strategies, objectives and

priorities; and advises on the development of

a national plan for family and intimate

violence and the development of new

technologies and their subsequent

application.

Matters To Be Discussed: The

subcommittee will discuss communications

and definitional issues for the Family and

Intimate Violence Prevention Program.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information: Ms.

Denise Johnson, Acting Team Leader, Family

and Intimate Violence Prevention Team,

Division of Violence Prevention, Mailstop K–

60, National Center for Injury Prevention and

Control, CDC, 4770 Buford Highway, NE,

Atlanta, Georgia 30341–3724, telephone 404/

488–4410.

Dated: February 27, 1995.

William H. Gimson,

Acting Associate Director for Policy

Coordination, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–5239 Filed 3–2–95; 8:45 am]

BILLING CODE 4163–18–M

Advisory Committee for Injury

Prevention and Control; Meeting

In accordance with section 19(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC),

announces the following committee

meeting.

Name: Advisory Committee for Injury

Prevention and Control (ACIPC).

Times and Dates: 1 p.m.–3:30 p.m., March

20, 1995; 8:30 a.m.–3:30 p.m., March 21,

1995.

Place: Holiday Inn at Lenox/Buckhead,

3377 Peachtree Road, NE, Atlanta, George

30326.

Status: Closed 1 p.m.–2 p.m., March 20,

and 8:30 a.m.–9 a.m., March 21; Open 2

p.m.–3:30 p.m., March 20, and 9 a.m.–3:30

p.m., March 21.

Purpose: The committee will continue to

make recommendations on policy, strategy,

objectives, and priorities including the

balance and mix of intramural and

extramural research; advise on the

implementation of a national plan for injury

prevention and control, the development of

new technologies and their application; and

review progress toward injury prevention

and control.

Matters To Be Discussed: The meeting will

convene in closed session from 1 p.m. to 2

p.m. on March 20, 1995. The purpose of this

closed session is for the Science and Program

Review Work Group to consider injury

control research grant applications

recommended for further consideration by

CDC’s Injury Research Grant Review

Committee. On March 21, 1995, from 8:30

a.m. to 9 a.m., the meeting will convene in

closed session in order for the full committee

to vote on a funding recommendation. These

portions of the meeting will be closed to the

public in accordance with provisions set

forth in section 552b(c) (4) and (6), title 5

U.S.C., and the Determination of the Acting

Associate Director for Policy Coordination,

CDC, pursuant to Pub. L. 92–463. Following

the closed sessions, the committee will

discuss (1) programmatic oversight, (2)

proposed program review, (3) issues

concerning NCIPC’s extramural research

grants program, (4) an update from the

Director, NCIPC, (5) updates on injury issues

from other Federal agencies, (6) a report on

the current and future issues in motor vehicle

injury control, and (7) a report from the

ACIPC Family and Intimate Violence

Prevention Subcommittee, and issues/

activities relating to family and intimate

violence.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information: Mr.

Tom Bartenfield, Acting Executive Secretary,

ACIPC, NCIPC, Mailstop K–60, CDC, 4770

Buford Highway, NE, Atlanta, Georgia

30341–3724, telephone 404/488–4690.

Dated: February 27, 1995.

William H. Gimson,

Acting Association Director for Policy

Coordination, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–5240 Filed 3–2–95; 8:45 am]

BILLING CODE 4163–18–M

National Institutes of Health

National Center for Human Genome

Research; Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting:

Name of Committee: Genome Research

Review Committee.

Date: March 14, 1995.

Time: 10 a.m. to adjournment.

Place: Embassy Suites Hotel, Chevy Chase

Pavilion, Washington, D.C.

Contact Person: Ms. Linda Engel, Chief,

Office of Scientific Review, National Center

for Human Genome Research, National

Institutes of Health, Building 38A, Room 604,

Bethesda, Maryland 20892, (301) 402–0838

Purpose/Agenda: To review and evaluate

grant applications and/or contract proposals.

The meeting will be closed in accordance

with the provisions set forth in secs. 552(c)(4)

and 552(c)(6), Title 5, U.S.C. Applications

and discussions could reveal confidential

trade secrets or commercial property such as

patentable material, and personal

information concerning individuals

associated with applications, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.172, Human Genome

Research)

Date: February 17, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–5231 Filed 3–2–95; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meeting:

Name of SEP: Program Project: Coronary

Atherosclerosis in Female Monkeys.

Date: March 16–17, 1995.

Time: 7:30 p.m.

Place: The Hawthorne Inn & Conference

Center, Winston-Salem, North Carolina.